Intravenous immunoglobulin for Guillain‐Barré syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for Guillain‐Barré Syndrome." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain���Barr��_syndrome. Accessed 03 December 2023.
Intravenous immunoglobulin for Guillain‐Barré syndrome. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain���Barr��_syndrome. Accessed December 3, 2023.
Intravenous immunoglobulin for Guillain‐Barré syndrome. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain���Barr��_syndrome
Intravenous Immunoglobulin for Guillain‐Barré Syndrome [Internet]. In: Cochrane Abstracts. [cited 2023 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain���Barr��_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for Guillain‐Barré syndrome
ID - 434987
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain���Barr��_syndrome
DB - Evidence Central
DP - Unbound Medicine
ER -